Cramer's Morning Take: Danaher 7/23/24
Squawk on the Street
July 23, 2024
Jim and Jeff discuss the smart plays by this life sciences stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. CNBC Investing Club Disclaimer Hosted by Simplecast, an AdsWizz company.
Speakers Jim Cramer, Jeff Marks
Jim Cramer (0:01)
Hey, it's Cramer, and this is my morning take on the market from today's CNBC Investing Club Morning Meeting.
We've got oil down, and we have interest rates kind of a little bit lower. And that is, by the way, what's still happening. We always forget, when we look at individual stocks, what's still controlling things is the Fed and whether rates are coming down. So we have all these different earnings that are being reported, and I come back to, you get a good backdrop, then you get a market that's going higher.
Jeff Marks (0:29)
Sure, and we've seen earnings come in today, generally better than expected. There are a few misses that we'll get to in the rapid fire section, but there was a nice beat today and a really strong outlook from Danahur in the portfolio as well. That stock is surging higher here, back to the 52-week high.
As the key line in the press release, they say the bioprocessing business sustained positive momentum, and that's key because when it was falling the last couple months, sentiment just got so poor in this group. You had a couple negative data points from peers. There was one last week, a peer in Germany reported a weak number, but I think the results show today why Danahur is just a much better-run company than what's in the group.
Jim Cramer (1:16)
And I think that analysts who have really kind of become lukewarm on Danahur are gonna come out very strong tomorrow, and that's one of the reasons why the stock can be up 18 today, because people realize when the analysts sit down with pen and paper today, they will come out hard tomorrow, as this was once the most loved company, and it's gonna get the love back.
Jeff Marks (1:36)
Sure, and you know what actually surprised me most about the quarter is they bought back stock, and they bought back a ton between 2Q and into July, 19 million shares, and why that's so notable, it's the first time they bought back stock in 10 years. So really, the bread and butter of the Dan and Her Playbook is you buy companies, you apply that Dan and Her business system operating playbook to improve efficiencies, margins, accelerate sales.
But this to me says, yeah, maybe the M&A environment not so great for them, but their stock, they can get a better return on buying their stock today when they can on M&A. And that's just a very bullish signal.
Jim Cramer (2:19)
Start your day with my out look on the market every morning. Visit cnbc.com/morningtake to become a CNBC Investing Club member at a special rate today.
SPEAKER_3 (2:32)
All opinions expressed by Jim Cramer on this podcast and in connection with the CNBC Investing Club are solely Cramer's opinions and do not reflect the opinions of CNBC, NBC Universal or their parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet or another medium.
No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Cramer. The opinions offered in connection with this podcast and the CNBC Investing Club are not an attempt to induce any particular trading behavior, investment or strategy. You should be aware of the risk of loss and following any strategy or investment discussed in the content from Cramer. To view the full CNBC Investing Club disclaimer, please visit cnbc.com forward slash investing club disclaimer.
Thousands of transcripts fetched by people building searchable podcast archives
Fetch the whole transcript
The demo key returns a sample episode in full, no card needed:
curl -H "x-api-key: pt_demo" \
https://spoken.md/transcripts/1000651996090Markdown with the speakers named, for your notes, your knowledge base, or anything that makes HTTP calls.
From $0.10 per transcript. No subscription. Credits never expire. Prices exclude VAT, added at checkout for EU customers. Not what you expected? Email us within 14 days with 20 or fewer credits used and we refund the pack in full.
Using your own key:
curl -H "x-api-key: YOUR_KEY" \
https://spoken.md/transcripts/1000663103311